Search results
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 17 hours agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap...
McKinsey advised drug companies on how to 'turbocharge' opioid sales. Now it's under criminal...
INSIDER via Yahoo News· 3 hours agoThe firm previously paid nearly $1 billion to resolve lawsuits related to its opioid work. The...
Sanofi crosses Sjögren’s off $5B drug’s hit list after phase 2 data disappoint
FierceBiotech· 38 minutes agoThe French drugmaker axed Sjögren’s syndrome from the list of targeted indications for frexalimab...
UPDATE 2-AstraZeneca trounces first-quarter estimates as resilient demand fuels growth
Reuters via Yahoo Finance· 1 hour agoOncology, the Anglo-Swedish drugmaker's top business, clocked a 26% jump in first-quarter sales to $5.12 billion. CEO Pascal Soriot has rebuilt the company's pipeline of new ...
How one state is trying to make weight loss drugs cheaper
NBC Universal via AOL· 10 hours agoWeight loss drugs aren't covered by insurance for North Carolina's state employees. The state is...
Xaira, an AI drug discovery startup, launches with a massive $1B, says it's 'ready' to start...
TechCrunch· 7 hours agoBiotech investors are making a big bet that similar computational methods could revolutionize drug...
Analyst Report: Evotec SE
Morningstar Research via Yahoo Finance· 4 hours agoThe EVT Execute segment, about 75% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis or integrated drug discovery ...
Sanofi to report earnings first-quarter earnings Thursday
WFMZ Eastern Pennsylvania and Western New Jersey· 14 hours agoSanofi, a drug company that has operations in Monroe County, will report first-quarter 2024 results...
Sanofi profit slips on generic competition and currency effects
Reuters via Yahoo Finance· 2 hours agoOperating income adjusted for one-offs slipped to...billion euros ($3.04 billion), a touch above the...
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical...
Morningstar· 19 hours ago...AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its subsidiary Algernon NeuroScience (AGN Neuro), along with the Centre for Human Drug Research (CHDR), will present its Phase 1 stroke study data at...
